Current treatment of ulcerative colitis.
Johannes Meier1, Andreas Sturm
1Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow Clinic, 13353 Berlin, Germany.
World Journal of Gastroenterology
|September 14, 2011
Summary
Ulcerative colitis (UC) treatment focuses on achieving steroid-free remission and preventing complications. Management strategies vary based on disease severity, location, and progression, guiding therapeutic choices from topical 5-aminosalicylic acid to advanced biologics and surgery.
Area of Science:
- Gastroenterology
- Internal Medicine
- Colorectal Surgery
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting the colon.
- Recurrent inflammation of the colonic mucosa characterizes UC, necessitating effective management strategies.
Purpose of the Study:
- To provide a practice-oriented overview of ulcerative colitis (UC) treatment.
- To outline key therapeutic considerations based on disease characteristics and patient response.
Main Methods:
- Review of current medical treatment options for UC.
- Integration of national and international consensus guidelines for UC management.
- Discussion of surgical indications and the importance of multidisciplinary collaboration.
Main Results:
- Treatment selection for UC is guided by disease severity, extent, and clinical course.
- Initial therapies include 5-aminosalicylic acid (5-ASA) compounds and corticosteroids.
- Refractory cases may require hospitalization and advanced therapies like calcineurin inhibitors, TNF-α antibodies, or immunomodulators.
- Emergency surgery is indicated for complications such as toxic megacolon, perforation, or severe bleeding.
Conclusions:
- A stepwise approach to UC treatment is essential for achieving remission and preventing complications.
- Close collaboration between gastroenterologists and surgeons is critical for timely intervention.
- Adherence to established guidelines ensures optimal patient care in ulcerative colitis management.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
705
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
705
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
755
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
755
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
692
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
692
01:26Peptic Ulcer Disease IV: Management
807
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
807
01:29Inflammatory Bowel Disease IV: Pharmacological Management
1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
1.1K
01:21Inflammatory Bowel Disease V: Surgical Management
917
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
917